We identified only one patient with a TGFB2 pathogenic variant, whose cardiovascular features consisted in mitral valve prolapse and insufficiency, mild arterial tortuosity and varicose veins, in the absence of aneurysms. This evidence concerns the gene TGFB2 and mitral valve disorder.